Suchergebnisse - "Ren, Shengxiang"

PubPharm (275)

1

Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease

enthalten in: Thoracic cancer | 2024

von Shao, C. | Zhi, X. | Mao, S. | +16

2

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non-small cell lung cancer : a multi-institutional retrospective cohort study

enthalten in: MedComm | 2024

von Wu, L. | Cheng, B. | Sun, X. | +9

3

A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Wang, L. | Luo, Y. | Ren, S. | +17

4

First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1% : results from a multicenter, open-label, phase 2 trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Ren, S. | Wang, X. | Han, B. | +19

5

Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment

enthalten in: Experimental hematology & oncology | 2024

von Qiao, M. | Zhou, F. | Liu, X. | +9

6

Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment

enthalten in: Experimental hematology & oncology | 2024

von Qiao, M. | Zhou, F. | Liu, X. | +9

7

EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation

enthalten in: The Journal of experimental medicine | 2024

von Qin, Z. | Yue, M. | Tang, S. | +30

8

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer : a multi‐institutional retrospective cohort study

enthalten in: MedComm | 2024

von Wu, L. | Cheng, B. | Sun, X. | +9

9

Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease

enthalten in: Thoracic Cancer | 2024

von Shao, C. | Zhi, X. | Mao, S. | +16

10

HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Jiang, T. | Jin, Q. | Wang, J. | +38

CommentIn: Clin Cancer Res. 2023 Dec 1;29(23):4706-4708. - PMID 37756560

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]